Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

Abroad (travel likely)RecruitingPHASE1

Conditions

Glioblastoma · Malignant Glioma · Recurrent Glioblastoma · Recurrent Malignant Glioma · Recurrent Grade III Glioma · Grade III Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Alabama at Birmingham, Children's of Alabama, Birmingham, Alabama, United States
Contact: Study coordinator (Girish Dhall, MD) · gdhall@peds.uab.edu · 205-638-9285
Contact: Study coordinator (Katie Metrock, MD) · kmetrock@peds.uab.edu
Children's Hospital of Los Angeles, Los Angeles, California, United States
Contact: Study coordinator (Tom Davidson, MD) · tdavidson@chla.usc.edu · 323-361-8147
Rady Children's Hospital, San Diego, California, United States
Contact: Study coordinator (Megan Paul, MD) · mrpaul@rchsd.org
University of California, San Francisco, San Francisco, California, United States
Contact: Study coordinator (Sabine Mueller, MD, Phd) · Sabine.Mueller@ucsf.edu
Contact: Principal Investigator (Sabine Mueller, MD)
Children's National Hospital, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Lindsay Kilburn, MD) · lkilburn@cnmc.org · 202-476-5973
University of Florida, Gainesville, Florida, United States
Contact: Study coordinator (Elias Sayour, MD, PhD) · elias.sayour@neurosurgery.ufl.edu · 352-294-8347
Riley Children's Hospital, Indianapolis, Indiana, United States
Contact: Study coordinator (Scott Coven, DO, MPH) · scoven@iu.edu · 317-944-8784
Contact: Principal Investigator (Scott Coven, DO, MPH)
Runco Daniel, MD, MS (Sub-investigator)
Johns Hopkins University, Baltimore, Maryland, United States
Contact: Study coordinator (Kenneth Cohen, MD, MBA) · kcohen@jhmi.edu · 410-614-5055
Contact: Study coordinator (Eric Raabe, MD) · eraabe2@jhmi.edu
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Susan Chi, MD) · susan_chi@dfci.harvard.edu · 617-632-2291
Washington University St. Louis, St Louis, Missouri, United States
Contact: Study coordinator (Mohamed Abdelbaki, MD) · mohameda@wustl.edu · 314-286-2790
Hackensack Meridian Children's Health at Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, United States
Contact: Study coordinator (Derek Hanson, MD) · derek.hanson@hmhn.org · 551-996-5437
Duke Children's Hospital & Health Center, Durham, North Carolina, United States
Contact: Study coordinator (Daniel Landi, MD, BS) · daniel.landi@duke.edu · 919-684-8111
Contact: Study coordinator (David Ashley, MBBS (Hon), FRACP, PhD) · david.ashley@duke.edu · 919-684-5580
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Cassie Kline, MD, MAS) · klinec@chop.edu · 267-426-5026
University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Nicholas Whipple, MD) · nicholas.whipple@hsc.utah.edu
Contact: Study coordinator (Priya Chan) · priya.chan@hsc.utah.edu
Sydney Children's Hospital, Sydney, New South Wales, Australia
Contact: Study coordinator (David Ziegler, BSc (Med), MBBS, FRACP, MD/PhD) · d.ziegler@unsw.edu.au · 61 2 9382 1111
The Children's Hospital at Westmead, Westmead, New South Wales, Australia
Contact: Study coordinator (Regienald Gayaman) · regienald.gayaman@health.nsw.gov.au · +61 2 9845 0925
Contact: Principal Investigator (Dinisha Govender, MBChB, FRACP)
Queensland Children's Hospital, South Brisbane, Queensland, Australia
Contact: Study coordinator (Natasha Brown) · natasha.brown@health.qld.gov.au · +61 7 3069 7206
Contact: Study coordinator (Karen Clements) · karen.clements@health.qld.gov.au · +61 7 3069 7441
Contact: Principal Investigator (Tim Hassall, MBBS, FRACP)
Women's and Children's Hospital, North Adelaide, South Australia, Australia
Contact: Study coordinator (Callie Ayles) · callie.ayles@sa.gov.au · (08) 81619162
Contact: Study coordinator (James Kirby) · James.Kirby@sa.gov.au · +61 8 8161 8922
Contact: Principal Investigator (Maria Kirby, MBBS FRACP)
Royal Children's Hospital, Parkville, Victoria, Australia
Contact: Study coordinator (Yun Y Tu) · yunyan.tu@mcri.edu.au · +61 3 9345 9184
Contact: Principal Investigator (Kanika Bhatia, MD)
Perth Children's' Hospital, Perth, Western Australia, Australia
Contact: Study coordinator (Nick Gottardo, MB,ChB,FRACP,PhD) · Nick.Gottardo@health.wa.gov.au

Study leads

Tom Davidson (tdavidson@chla.usc.edu), MD
Study Chair
Children's Hospital Los Angeles

View source on ClinicalTrials.gov Contact study team (email)